文献速递新发突发、热带与寄生虫病

非洲恶性疟原虫PfCRT突变体介导哌喹耐药者少见且付出较大适合度代价

Plasmodium falciparum African PfCRT Mutant Isoforms Conducive to Piperaquine Resistance Are Infrequent and Impart a Major Fitness Cost.
PubMed 文献 · J Infect Dis · 2025-01-01

研究将东南亚已知介导哌喹耐药的PfCRT突变编辑入表达3种非洲常见PfCRT单倍型的恶性疟原虫无性血阶段虫株,进行抗疟药浓度-反应和竞争适合度试验。结果显示这些突变仅在罕见的FCB单倍型上介导中度哌喹耐药,且耐药虫株生长速率降低,提示适合度代价可能限制其在非洲高传播区扩散。

要点

  • T93S或I218F突变加入非洲常见GB4和Cam783单倍型不介导哌喹耐药。
  • 这些突变在罕见FCB单倍型上获得中度哌喹耐药。
  • 耐药非洲PfCRT突变体表现出血阶段生长速率降低的适合度代价。

核心结论

  • 东南亚出现的哌喹耐药PfCRT突变仅在有限 subset 非洲PfCRT单倍型中介导耐药,其适合度代价可能阻止其在非洲高传播疟疾流行区扩散。

研究设计与样本

  • 研究将已知介导东南亚哌喹耐药的PfCRT突变编辑入表达3种非洲常见突变PfCRT单倍型的恶性疟原虫无性血阶段虫株,并对基因编辑克隆进行抗疟药浓度-反应和竞争适合度试验。

主要发现

  • 表达当代东南亚T93S或I218F突变的pfcrt编辑虫株(加入非洲常见GB4和Cam783单倍型)不介导哌喹耐药,仅在低药物浓度下部分存活。
  • 这些突变在罕见PfCRT FCB单倍型(主要见于东北非)上表达时,虫株获得中度哌喹耐药。
  • 编辑表达T93S或I218F突变的Dd2GB4、Dd2Cam783和Dd2FCB株对氯喹敏感性增加。
  • 哌喹耐药非洲PfCRT同工型带来 substantial 适合度代价,表现为无性血阶段寄生虫生长速率降低。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Piperaquine, used in combination with dihydroartemisinin, has been identified as a promising partner drug for uncomplicated treatment and chemoprevention of Plasmodium falciparum malaria in Africa. In light of the earlier spread of piperaquine resistance in Southeast Asia, mediated primarily by mutations in the drug efflux transporter PfCRT, we have explored whether PfCRT mutations would represent a probable path to piperaquine resistance becoming established in Africa. METHODS: We edited PfCRT mutations known to mediate piperaquine resistance in Southeast Asia into P falciparum asexual blood-stage parasites expressing 3 prevalent African mutant PfCRT haplotypes. Gene-edited clones were profiled in antimalarial concentration-response and competitive fitness assays. RESULTS: pfcrt-edited parasites expressing the contemporary Southeast Asian T93S or I218F mutations added to the GB4 and Cam783 haplotypes common in Africa did not mediate piperaquine resistance, with partial survival only at low drug concentrations. In contrast, parasites expressing these mutations on the rare PfCRT FCB haplotype, observed mostly in Northeast Africa, acquired a moderate level of piperaquine resistance. Dd2GB4, Dd2Cam783, and Dd2FCB lines edited to express the T93S or I218F mutations showed increased susceptibility to chloroquine. Piperaquine-resistant African PfCRT isoforms conferred a substantial fitness cost, manifesting as reduced asexual blood-stage parasite growth rates. CONCLUSIONS: These findings suggest that piperaquine-resistant PfCRT mutations that emerged in Southeast Asia mediate resistance only in a limited subset of African PfCRT haplotypes, with fitness costs that we suspect would likely preclude dissemination in high-transmission malaria-endemic African regions.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Hagenah LM, Yeo T, Schindler KA, et al. Plasmodium falciparum African PfCRT Mutant Isoforms Conducive to Piperaquine Resistance Are Infrequent and Impart a Major Fitness Cost. J Infect Dis. 2025. PMID: 39661643. doi:10.1093/infdis/jiae617

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。